Takeda s tetravalent dengue vaccine (TAK-003) receives first global approval for use in Indonesia without need for pre-vaccination testing
asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.
Takeda Pharmaceuticals Marks its 240th Founding Anniversary
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Takeda named Top Employer in Mideast again
DUBAI, January 27, 2021 Takeda, a global biopharmaceutical leader headquartered in Japan, has been named a Top Employer in 2021 in the Middle East for the second consecutive year by Top Employers Institute. This is also the fourth year in a row Takeda has received the prestigious global Top Employer status. Apart from Saudi Arabia and the UAE, Takeda also received regional certifications for Asia Pacific, Europe and Latin America, with India, Ukraine, Kazakhstan, Algeria and Turkey also being similarly awarded. 38 Takeda local operating companies were accredited this year around the world. Dr Mahender Nayak, Area Head for ICMEA (India, CIS., Middle East, Turkey, and Africa) at Takeda said: “Our team is the cornerstone of our long-term growth strategy that seeks to drive positive patient outcomes. By creating an exceptional people experience we are committed to maintain a vibrant, diverse and inclusive workplace that prov